Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation on Efficacy and Tolerability of Prospan® Hustenzäpfchen for the Symptomatic Treatment of Acute Bronchitis Accompanied by Coughing in Children

NCT01127048 is registered in ClinicalTrials.gov with Engelhard Arzneimittel GmbH & Co.KG as lead sponsor.

NCT NCT01127048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01127048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation on Efficacy and Tolerability of Prospan® Hustenzäpfchen for the Symptomatic Treatment of Acute Bronchitis Accompanied by Coughing in Children
Lead sponsor
Engelhard Arzneimittel GmbH & Co.KG
Phase
Phase 3
Overall status
Unknown status
Start date
October 31, 2008
Completion date
August 31, 2013
Enrollment
1,400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

symptoms of acute bronchitis accompanied by coughing